Recurrent platinum-resistant fallopian tube carcinoma

Clinical trials for Recurrent platinum-resistant fallopian tube carcinoma explained in plain language.

Never miss a new study

Get alerted when new Recurrent platinum-resistant fallopian tube carcinoma trials appear

Sign up with your email to follow new studies for Recurrent platinum-resistant fallopian tube carcinoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 3

Supercharged immune cells take on tough ovarian cancers

Disease control Recruiting now

This early-phase study tests a new treatment for people with ovarian cancer that has returned or is resistant to standard platinum chemotherapy. The treatment uses a patient's own immune cells (T cells), which are trained in a lab to recognize and attack a protein called MUC1 fou…

Matched conditions: RECURRENT PLATINUM-RESISTANT FALLOPIAN TUBE CARCINOMA

Phase 1 • Sponsor: Mayo Clinic • Aim: Disease control

Last updated Jun 27, 2026 11:01 UTC

Recurrent platinum-resistant fallopian tube carcinoma

Get alerted when new Recurrent platinum-resistant fallopian tube carcinoma trials appear

Supercharged immune cells take on tough ovarian cancers